NDC 0002-2377 – Emgality

Galcanezumab 120 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0002-2377

Product details

Brand name
Emgality
Generic name
Galcanezumab-gnlm
Labeler
Eli Lilly and Company
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761063
Marketed since
September 27, 2018
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Emgality →

Package NDC codes (1)

Package NDCDescriptionSince
0002-2377-111 SYRINGE in 1 CARTON (0002-2377-11) / 1 mL in 1 SYRINGE (0002-2377-01)Jan 18, 2019

Other Emgality products